Milae Bioresources Statistics

Total Valuation

Milae Bioresources has a market cap or net worth of KRW 74.77 billion. The enterprise value is 55.00 billion.

Market Cap	74.77B
Enterprise Value	55.00B

Important Dates

The next estimated earnings date is Thursday, March 20, 2025.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Milae Bioresources has 19.50 million shares outstanding. The number of shares has increased by 2.03% in one year.

Current Share Class	n/a
Shares Outstanding	19.50M
Shares Change (YoY)	+2.03%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	53.08%
Owned by Institutions (%)	4.66%
Float	8.94M

Valuation Ratios

The trailing PE ratio is 220.61.

PE Ratio	220.61
Forward PE	n/a
PS Ratio	1.18
PB Ratio	1.67
P/TBV Ratio	1.72
P/FCF Ratio	1,931.67
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 56.39, with an EV/FCF ratio of 1,420.99.

EV / Earnings	159.32
EV / Sales	0.87
EV / EBITDA	56.39
EV / EBIT	n/a
EV / FCF	1,420.99

Financial Position

The company has a current ratio of 3.95, with a Debt / Equity ratio of 0.12.

Current Ratio	3.95
Quick Ratio	3.40
Debt / Equity	0.12
Debt / EBITDA	5.46
Debt / FCF	137.62
Interest Coverage	-0.02

Financial Efficiency

Return on equity (ROE) is 0.57% and return on invested capital (ROIC) is -0.01%.

Return on Equity (ROE)	0.57%
Return on Assets (ROA)	-0.01%
Return on Capital (ROIC)	-0.01%
Revenue Per Employee	1.35B
Profits Per Employee	7.34M
Employee Count	47
Asset Turnover	1.11
Inventory Turnover	11.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.29% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-8.29%
50-Day Moving Average	4,234.20
200-Day Moving Average	4,709.58
Relative Strength Index (RSI)	43.77
Average Volume (20 Days)	207,878

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Milae Bioresources had revenue of KRW 63.45 billion and earned 345.21 million in profits. Earnings per share was 17.38.

Revenue	63.45B
Gross Profit	7.94B
Operating Income	-8.90M
Pretax Income	65.19M
Net Income	345.21M
EBITDA	975.28M
EBIT	-8.90M
Earnings Per Share (EPS)	17.38

Full Income Statement

Balance Sheet

The company has 25.03 billion in cash and 5.33 billion in debt, giving a net cash position of 19.70 billion or 1,010.65 per share.

Cash & Cash Equivalents	25.03B
Total Debt	5.33B
Net Cash	19.70B
Net Cash Per Share	1,010.65
Equity (Book Value)	44.72B
Book Value Per Share	2,296.98
Working Capital	31.60B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 253.09 million and capital expenditures -214.38 million, giving a free cash flow of 38.71 million.

Operating Cash Flow	253.09M
Capital Expenditures	-214.38M
Free Cash Flow	38.71M
FCF Per Share	1.99

Full Cash Flow Statement

Margins

Gross margin is 12.51%, with operating and profit margins of -0.01% and 0.54%.

Gross Margin	12.51%
Operating Margin	-0.01%
Pretax Margin	0.10%
Profit Margin	0.54%
EBITDA Margin	1.54%
EBIT Margin	-0.01%
FCF Margin	0.06%

Dividends & Yields

Milae Bioresources does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.03%
Shareholder Yield	-2.03%
Earnings Yield	0.45%
FCF Yield	0.05%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Milae Bioresources has an Altman Z-Score of 7.46.

Altman Z-Score	7.46
Piotroski F-Score	n/a